Company Filing History:
Years Active: 2006-2007
Title: The Innovations of Kingman Ng: Pioneering GLP-1 and Insulin Combinations
Introduction: Kingman Ng is an accomplished inventor based in Carmel, IN, with a notable portfolio consisting of three patents. His work primarily focuses on advancements in pharmaceutical formulations that aim to improve diabetic treatments through innovative mixtures of GLP-1 and insulin.
Latest Patents: Among his latest patents is the invention of pre-mixed formulations comprising a GLP-1 polypeptide and a basal insulin. This groundbreaking invention provides new options for patients requiring insulin therapy. Additionally, he developed biphasic mixtures of GLP-1 and insulin, which involve a pharmaceutical formulation containing a solid phase of glucagon-like peptide (GLP-1) and a solution phase of insulin. These innovations represent significant strides in the management of diabetes.
Career Highlights: Kingman Ng is currently employed by Eli Lilly and Company, a leading global pharmaceutical company. His contributions to research and development in the field of diabetes therapies underscore his expertise and commitment to enhancing patient care through innovative approaches.
Collaborations: Throughout his career, Ng has collaborated with noted professionals in his field, including Michael Rosario DeFelippis and Richard Dennis DiMarchi. These partnerships have likely enhanced the scope and impact of his research and inventions.
Conclusion: Kingman Ng continues to make significant contributions to the pharmaceutical industry with his patents focusing on GLP-1 and insulin combinations. His innovations are critical in the ongoing battle against diabetes, helping to improve the quality of life for many patients while showcasing the importance of research and development in the health sector.